+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ameluz"

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 170 Pages
  • Global
From
Actinic Keratosis Treatment Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Actinic Keratosis Treatment Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 140 Pages
  • Global
From
U.S. Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical/Drugs, Surgery, Photodynamic Therapy), By Drug Class, By Product, By End-use, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

U.S. Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical/Drugs, Surgery, Photodynamic Therapy), By Drug Class, By Product, By End-use, And Segment Forecasts, 2023 - 2030

  • Report
  • January 2023
  • 150 Pages
  • United States
From
Actinic Keratosis Treatment Market - Growth, Trends, and Forecasts (2023 - 2028) - Product Thumbnail Image

Actinic Keratosis Treatment Market - Growth, Trends, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 120 Pages
  • Global
From
Market Spotlight: Basal Cell Carcinoma (2020) - Product Thumbnail Image

Market Spotlight: Basal Cell Carcinoma (2020)

  • Report
  • March 2020
  • 33 Pages
  • Global
Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 245 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Ameluz market is a segment of the skin cancer drugs market. It is composed of products that are used to treat actinic keratosis, a precancerous skin condition. These products are typically topical creams or gels that contain aminolevulinic acid, a photosensitizing agent. When exposed to light, the agent causes the destruction of abnormal cells. The Ameluz market is a growing segment of the skin cancer drugs market, as it offers a safe and effective treatment for actinic keratosis. Companies in the Ameluz market include Galderma, Sun Pharmaceuticals, and Biofrontera. Galderma is a Swiss-based pharmaceutical company that produces the Ameluz brand of topical cream. Sun Pharmaceuticals is an Indian-based company that produces the Solaraze brand of topical gel. Biofrontera is a German-based company that produces the BF-RhodoLED brand of topical gel. Show Less Read more